November 30 (SeeNews) - Bulgarian drug distributor Sopharma Trading [BUL:SO5] said on Wednesday its net profit fell to 8.45 million levs ($4.59 million/4.32 million euro) in the first nine months of 2016, from 10.25 million levs in the like period of 2015.
Sales revenue decreased slightly to 447.9 million levs, from 449.1 million levs a year earlier, the company said in a bourse filing.
Cost of goods sold edged down to 413.5 million levs, from 414.7 million levs.
Distribution costs rose to 17.3 million levs, from 14.9 million levs .
Sopharma Trading is a unit of Bulgarian drug maker Sopharma [BUL:3JR].
Sopharma Trading [BUL:SO5] shares traded 1.37% higher at 6.285 levs per share by 15:00 CET on the Sofia bourse.
(1 euro = 1.95583 levs)